CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Kehua Bio-Engineering Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Kehua Bio-Engineering Co Ltd
No.1189
Qinzhou North Road, Xuhui District
Phone: +86 2164954576p:+86 2164954576 SHANGHAI, SHA  200233  China Ticker: 002022002022
Business Summary
Shanghai Kehua Bio-Engineering Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of in vitro diagnostic reagents and medical testing instruments. The Company's products include reagents and instruments. Reagent products cover fields such as infectious diseases, cardiovascular health, liver disease, kidney disease, oncology, reproductive health, maternal and child health, genetic disease testing, pharmacogenomics, and animal disease testing. Instrument products cover biochemical diagnostics, immunodiagnostics, molecular diagnostics, point-of-care testing (POCT), and mass spectrometry. The Company distributes its products within the domestic market and to overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President MingLi 49 3/20/2024 4/3/2023
Vice Chairman of the Board ZhichaoMa 45 3/20/2024 9/21/2022
Chief Financial Officer FangLuo 53 1/5/2016 1/5/2016
9 additional Officers and Directors records available in full report.

Business Names
Business Name
002022
Shanghai Kehua Bio-Engineering Co., Ltd.
Shanghai Kehua Dongling Diagnostic Product Co. Ltd.
Technogenetics Holdings S.r.l
Technogenetics srl

General Information
Number of Employees: 2,033 (As of 12/31/2024)
Outstanding Shares: 514,348,244 (As of 9/30/2025)
Shareholders: 44,346
Stock Exchange: SHE
Fax Number: +86 2164851044


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 4, 2025